We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Principal researcher confirms trial participants with a history of hypoglycemia unawareness are now insulin independent. Funding cell replacement therapies research is one of JDRF’s most critical undertakings globally, in its efforts to support the most promising cure-based research into type 1 diabetes (T1D). On January 10, 2022, Sernova Corp. provided a progress update on […]
January 23rd marks the 100th Anniversary of the first successful insulin injection JDRF’s primary goal is to cure type 1 diabetes (T1D) through research – as quickly as possible. To support people with T1D while cure research is advancing, we also fund ground-breaking research that seeks to make life with T1D easier, safer and healthier. […]
JDRF is committed to providing timely information about the latest research updates relevant to the diabetes community. Early January 2022 researchers from the Centers for Disease Control and Prevention (CDC) in the United States reported that children who have recovered from COVID-19 may be at an increased risk of being diagnosed with diabetes. The CDC’s […]
What is the Coxsackie B virus and how does it relate to diabetes? JDRF is committed to funding the most promising research into cures for diabetes, and better understanding the mechanisms of the disease. One of the most significant challenges of preventing or curing type 1 diabetes (T1D) is that we don’t yet know its […]
A recent study held in Australia sought to answer the question: for children and adolescents with type 1 diabetes (T1D), does a hybrid closed-loop (HCL) system improve glycemic and psychosocial outcomes compared with conventional management? The study set out to compare the glycemic control or Time in Range (TIR) and the psychosocial outcomes of a […]
JDRF is committed to providing the T1D community with the most up-to-date and relevant information about the ongoing COVID-19 pandemic and its impact on those living with the disease. As of January 2022, Canada is once again amid what appears to be the worst wave of the pandemic, with the emergence of the Omicron variant. […]
2021 was a year of strength and we believe that 2022 will be one of hope. Canadians are resilient, and though this pandemic continues to challenge, the tenacious spirit of the JDRF community never wavered. As a result, JDRF was able to progress our important work in supporting the research that will bring us closer […]
The holiday season is upon us, and with it, the stress that can come with trying to find that perfect gift for the special people in your life. Let JDRF help with your shopping. We’ve put together a gift guide with a few creative ideas for your loved ones living with type 1 diabetes – […]
*Image taken from viacyte.com/pipeline/ A significant focus of JDRF is funding the most promising research that could lead to potential cure therapies for type 1 diabetes (T1D). ViaCyte, a cell replacement company long supported by JDRF, has three separate stem cell replacement therapy products in development, all with the aim of reducing or eliminating the […]
Tannis, along with her late husband George T. Richardson, were founding members of JDRF’s Winnipeg chapter (1971) and the city’s A Starry Starry Night Gala in support of JDRF. Tannis has also been on both the national and international boards for JDRF, which was formally established in Canada in 1974. At 95 years old, Tannis […]
Why advocacy matters The driving force behind JDRF’s government relations and advocacy strategy is to help Canada’s decision-makers understand the impact of type 1 diabetes (T1D) and what needs to be done to improve the lives of those affected by the disease. We put T1D on the government agenda by actively participating in the legislative […]
The Sun Life Ride to Defeat Diabetes for JDRF took place on October 7, 2021. For the second straight year, the Ride was a virtual event that offered a fun corporate team building experience all with the goal of turning type 1 diabetes (T1D) into type none. 735 teams from more than 160 Canadian companies joined us to Spin, Sweat or Stretch throughout the day. […]
Notifications
